Does OFATUMUMAB Cause Disease progression? 263 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 263 reports of Disease progression have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.9% of all adverse event reports for OFATUMUMAB.
263
Reports of Disease progression with OFATUMUMAB
0.9%
of all OFATUMUMAB reports
38
Deaths
13
Hospitalizations
How Dangerous Is Disease progression From OFATUMUMAB?
Of the 263 reports, 38 (14.4%) resulted in death, 13 (4.9%) required hospitalization, and 6 (2.3%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 263 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which OFATUMUMAB Alternatives Have Lower Disease progression Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB